X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5932) 5932
Book Review (553) 553
Publication (453) 453
Newsletter (174) 174
Magazine Article (41) 41
Dissertation (36) 36
Book Chapter (30) 30
Conference Proceeding (19) 19
Newspaper Article (19) 19
Trade Publication Article (8) 8
Web Resource (5) 5
Government Document (3) 3
Book / eBook (2) 2
Data Set (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rosiglitazone (5099) 5099
index medicus (3786) 3786
humans (2597) 2597
male (1752) 1752
animals (1567) 1567
thiazolidinediones (1375) 1375
female (1353) 1353
pioglitazone (1106) 1106
diabetes mellitus, type 2 - drug therapy (1086) 1086
endocrinology & metabolism (1066) 1066
hypoglycemic agents - therapeutic use (1066) 1066
diabetes (1050) 1050
thiazolidinediones - therapeutic use (1000) 1000
type 2 diabetes (977) 977
thiazolidinediones - pharmacology (966) 966
middle aged (922) 922
pharmacology & pharmacy (867) 867
mice (840) 840
metformin (802) 802
rosiglitazone maleate (791) 791
rats (767) 767
insulin resistance (763) 763
ppar-gamma (751) 751
insulin (693) 693
hypoglycemic agents - pharmacology (658) 658
insulin-resistance (654) 654
aged (628) 628
adult (619) 619
risk factors (576) 576
risk (569) 569
research (568) 568
drug therapy (541) 541
hypoglycemic agents - adverse effects (534) 534
expression (529) 529
glucose (523) 523
ppar gamma - agonists (516) 516
diabetes mellitus (504) 504
thiazolidinediones - adverse effects (501) 501
ppar gamma - metabolism (476) 476
inflammation (472) 472
troglitazone (444) 444
abridged index medicus (443) 443
medicine, general & internal (433) 433
obesity (396) 396
activated-receptor-gamma (386) 386
metabolism (384) 384
mellitus (382) 382
treatment outcome (368) 368
health aspects (367) 367
thiazolidinediones - administration & dosage (365) 365
biochemistry & molecular biology (363) 363
blood glucose - metabolism (359) 359
hypoglycemic agents - administration & dosage (355) 355
dosage and administration (352) 352
care and treatment (346) 346
diabetes mellitus, type 2 - blood (338) 338
gene-expression (333) 333
drug therapy, combination (329) 329
complications and side effects (326) 326
myocardial-infarction (326) 326
hypoglycemic agents (319) 319
type-2 diabetes-mellitus (319) 319
activated receptor-gamma (318) 318
physiological aspects (314) 314
therapy (308) 308
glycemic control (303) 303
pparγ (296) 296
cell biology (293) 293
gene expression (291) 291
medicine & public health (289) 289
medicine, research & experimental (289) 289
ppar gamma (288) 288
ligands (285) 285
apoptosis (284) 284
rodents (281) 281
oxidative stress (279) 279
analysis (278) 278
metformin - therapeutic use (273) 273
diabetes mellitus, type 2 - complications (268) 268
disease (266) 266
thiazolidinedione (265) 265
internal medicine (262) 262
cells, cultured (260) 260
mice, inbred c57bl (253) 253
disease models, animal (251) 251
clinical trials (248) 248
drugs (247) 247
research article (246) 246
adipose-tissue (245) 245
diabetes therapy (245) 245
metabolic syndrome (245) 245
article (242) 242
atherosclerosis (238) 238
cardiac & cardiovascular systems (238) 238
type 2 diabetes mellitus (234) 234
dose-response relationship, drug (233) 233
rats, sprague-dawley (231) 231
double-blind method (230) 230
differentiation (229) 229
ppar gamma - genetics (221) 221
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5985) 5985
German (56) 56
French (48) 48
Korean (48) 48
Spanish (37) 37
Chinese (33) 33
Portuguese (9) 9
Russian (9) 9
Japanese (8) 8
Hungarian (4) 4
Polish (4) 4
Turkish (4) 4
Czech (2) 2
Italian (2) 2
Bosnian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ: British Medical Journal, ISSN 0959-8138, 9/2010, Volume 341, Issue 7772, pp. c5279 - c5279
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 11/2011, Volume 45, Issue 11, pp. 1416 - 1424
Journal Article
03/2010
Sustained nitroglycerin (GTN) therapy impairs endothelial function in healthy volunteers and patients with cardiovascular disease, caused by an increase in... 
rosiglitazone | 0419 | endothelial dysfunction
Dissertation
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2010, Volume 12, Issue 8, pp. 716 - 721
Journal Article
12/2010
Purpose: The aim of this work was to synthesize superporous hydrogels of rosiglitazone using chitosan and to study its swelling behaviour for application as a... 
Swelling | Rosiglitazone | Gastroretentive | Porous hydrogels | Chitosan
Web Resource
DIABETES CARE, ISSN 0149-5992, 05/2014, Volume 37, Issue 5, pp. 1367 - 1374
OBJECTIVETo describe market trends for antidiabetic drugs, focusing on newly approved drugs, concomitant use of antidiabetic drugs, and effects of safety... 
METFORMIN | COST | MEDICAL THERAPY | SAFETY | ENDOCRINOLOGY & METABOLISM | BARIATRIC SURGERY | RISK | PATTERNS | ROSIGLITAZONE | TRENDS | CARE
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 24, pp. 2247 - 2256
Journal Article
08/2012
Purpose: Peroxisome proliferator-activated receptor (PPAR)-γ ligand is known to repress the expression of pro-inflammatory mediators. However, it is unclear... 
Acute lung injury | Rosiglitazone | IL-8 | PPAR-γ expression | IL-6
Web Resource
08/2012
Purpose: Peroxisome proliferator-activated receptor (PPAR)-γ ligand is known to repress the expression of pro-inflammatory mediators. However, it is unclear... 
Acute lung injury | Rosiglitazone | IL-8 | PPAR-γ | IL-6
Web Resource
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 03/2010, Volume 303, Issue 12, pp. 1194 - 1195
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 12/2009, Volume 20, Issue 12, pp. 2481 - 2483
Journal Article
Biochemical and biophysical research communications, 09/2019
Activation of perivascular mast cells (MCs) and subsequent release of their abundant inflammatory mediators have been well documented to induce excessive... 
Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 12/2018, Volume 9, Issue 102, pp. 37614 - 37615
Journal Article
Lipids, ISSN 0024-4201, 02/2019, Volume 54, Issue 2-3, pp. 141 - 148
In the current investigation, the effect of epigallocatechin gallate (EGCG) on the phosphorylation of IRS1 and Akt molecules in insulin-resistant C2C12 muscle... 
Type 2 diabetes | Rosiglitazone | Akt | Epigallocatechin gallate (EGCG) | IRS1
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 10/2017, Volume 142, pp. 168 - 193
Diabetes mellitus is a chronic disease characterized by hyperglycemia, insulin resistance and hyperlipidemia. Glitazones or thiazolidinediones (TZD) are drugs... 
Molecular dynamics | Rosiglitazone | Docking | 15d-PGJ2 | Pioglitazone | Troglitazone
Journal Article
American Family Physician, ISSN 0002-838X, 01/2014, Volume 89, Issue 2, p. 114
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.